Cerebroprotection by dioscin after experimental subarachnoid haemorrhage via inhibiting NLRP3 inflammasome through SIRT1‐dependent pathway
British Journal of Pharmacology2021Vol. 178(18), pp. 3648–3666
Citations Over TimeTop 10% of 2021 papers
Xiangsheng Zhang, Yue Lu, Wen Li, Tao Tao, Wei‐Han Wang, Sen Gao, Yan Zhou, Yi‐Ting Guo, Cang Liu, Zong Zhuang, Chun‐Hua Hang, Wei Li
Abstract
Dioscin provides protection against subarachnoid haemorrhage via the suppression of NLRP3 inflammasome activation through SIRT1-dependent pathway. Dioscin may be a new candidate to ameliorate early brain injury after subarachnoid haemorrhage.
Related Papers
- → Cloning and Characterization of Rat BAT3 cDNA(1999)20 cited
- Molecular mechanisms regulating NLRP3 inflammasome activation(2016)
- The inflammasome as future therapeutic target: Development of inflammasome challenge tests(2014)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)